FDA approves pralatrexate for treatment of rare lymphoma.
Cheryl A
CA
Thompson
D000630:Aminopterin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017277:Drug Approval; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D016411:Lymphoma, T-Cell, Peripheral / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
C418863:10-propargyl-10-deazaaminopterin; D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; D000630:Aminopterin